Antinuclear Antibody Testing Market - Global Outlook and Forecast 2023-2028

Report ID: 1566669 | Published Date: Jan 2025 | No. of Page: 62 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story

An antinuclear antibody tests (ANA) are used to evaluate quantity and pattern of antibodies in the blood.
This report contains market size and forecasts of Antinuclear Antibody Testing in Global, including the following market information:
Global Antinuclear Antibody Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Antinuclear Antibody Testing market was valued at 1208.4 million in 2021 and is projected to reach US$ 1801 million by 2028, at a CAGR of 5.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Reagents & Assay Kits Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Antinuclear Antibody Testing include Alere, Inc., Abbott Laboratories, Antibodies, Inc., Bio-Rad Laboratories, Inc., Biocom Biotech, Erba Diagnostics, Inc., Euroimmun AG, HUMAN Diagnostics, Inc. and Immuno Concepts, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antinuclear Antibody Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antinuclear Antibody Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Antinuclear Antibody Testing Market Segment Percentages, by Type, 2021 (%)
Reagents & Assay Kits
Software & Services
Systems
Global Antinuclear Antibody Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Antinuclear Antibody Testing Market Segment Percentages, by Application, 2021 (%)
Rheumatoid Arthritis
Scleroderma
Systemic Lupus Erythematosus
Sjögren’s Syndrome
Other Diseases
Global Antinuclear Antibody Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Antinuclear Antibody Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antinuclear Antibody Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Antinuclear Antibody Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alere, Inc.
Abbott Laboratories
Antibodies, Inc.
Bio-Rad Laboratories, Inc.
Biocom Biotech
Erba Diagnostics, Inc.
Euroimmun AG
HUMAN Diagnostics, Inc.
Immuno Concepts, Inc.
Inova Diagnostics, Inc.
Thermo Fisher Scientific, Inc.
Trinity Biotech Plc
Zeus Scientific, Inc.

Frequently Asked Questions
Antinuclear Antibody Testing Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Antinuclear Antibody Testing Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Antinuclear Antibody Testing Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports